Therini Bio

Therini Bio

A biotechnology company dedicated to the research and development of novel therapeutics for the treatment of neuroinflammatory diseases due to vascular dysfunction.

Launch date
Employees
Market cap
-
Enterprise valuation
€131—196m (Dealroom.co estimates Apr 2023.)
San Francisco California (HQ)

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.